GEP20032926B - Tetrahydropyridoethers - Google Patents

Tetrahydropyridoethers

Info

Publication number
GEP20032926B
GEP20032926B GEAP19995786A GEAP1999005786A GEP20032926B GE P20032926 B GEP20032926 B GE P20032926B GE AP19995786 A GEAP19995786 A GE AP19995786A GE AP1999005786 A GEAP1999005786 A GE AP1999005786A GE P20032926 B GEP20032926 B GE P20032926B
Authority
GE
Georgia
Prior art keywords
tetrahydropyridoethers
essence
effectiveness
compounds
formula
Prior art date
Application number
GEAP19995786A
Other languages
English (en)
Inventor
Ernst Sturm
Reinhard Huber
Gerhard Grundler
Stefan Postius
Wolfgang Kromer
Guido Hanauer
Wolfgang-Alexander Simon
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of GEP20032926B publication Critical patent/GEP20032926B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GEAP19995786A 1998-09-23 1999-09-17 Tetrahydropyridoethers GEP20032926B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23

Publications (1)

Publication Number Publication Date
GEP20032926B true GEP20032926B (en) 2003-03-25

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19995786A GEP20032926B (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Country Status (31)

Country Link
US (4) US6436953B1 (cg-RX-API-DMAC7.html)
EP (1) EP1115725B1 (cg-RX-API-DMAC7.html)
JP (1) JP4145492B2 (cg-RX-API-DMAC7.html)
KR (1) KR100668400B1 (cg-RX-API-DMAC7.html)
CN (2) CN1155598C (cg-RX-API-DMAC7.html)
AT (1) ATE231862T1 (cg-RX-API-DMAC7.html)
AU (1) AU763463B2 (cg-RX-API-DMAC7.html)
BG (1) BG65195B1 (cg-RX-API-DMAC7.html)
BR (1) BR9914044A (cg-RX-API-DMAC7.html)
CA (1) CA2344251A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ292335B6 (cg-RX-API-DMAC7.html)
DE (1) DE69905178T2 (cg-RX-API-DMAC7.html)
DK (1) DK1115725T3 (cg-RX-API-DMAC7.html)
EA (1) EA005377B1 (cg-RX-API-DMAC7.html)
EE (1) EE04677B1 (cg-RX-API-DMAC7.html)
ES (1) ES2191464T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20032926B (cg-RX-API-DMAC7.html)
HK (1) HK1038360B (cg-RX-API-DMAC7.html)
HR (1) HRP20010224A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0102990A3 (cg-RX-API-DMAC7.html)
ID (1) ID28896A (cg-RX-API-DMAC7.html)
IL (2) IL142063A0 (cg-RX-API-DMAC7.html)
NO (1) NO317304B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510610A (cg-RX-API-DMAC7.html)
PL (1) PL193616B1 (cg-RX-API-DMAC7.html)
PT (1) PT1115725E (cg-RX-API-DMAC7.html)
RS (1) RS50145B (cg-RX-API-DMAC7.html)
SI (1) SI1115725T1 (cg-RX-API-DMAC7.html)
SK (1) SK285165B6 (cg-RX-API-DMAC7.html)
TR (1) TR200100805T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000017200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292335B6 (cs) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethery, jejich použití a farmaceutický prostředek
US6503923B1 (en) 1999-04-17 2003-01-07 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
MXPA02009549A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Imidazopiridinas triciclicas.
ATE311389T1 (de) * 2000-03-29 2005-12-15 Altana Pharma Ag Wirkstoffvorläufer von imidazopyridin-derivaten
CN1692113A (zh) * 2000-10-25 2005-11-02 奥坦纳医药公司 作为胃分泌抑制剂的多取代咪唑并吡啶
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
EP1414821B1 (en) 2001-08-02 2006-08-16 ALTANA Pharma AG Tricyclic epoxides
CN1656096A (zh) * 2001-08-03 2005-08-17 奥坦纳医药公司 用于治疗胃肠病症的烷基－取代的咪唑吡啶
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EP1476445A1 (en) 2002-02-15 2004-11-17 ALTANA Pharma AG Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003227710A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
KR20050088176A (ko) * 2002-12-20 2005-09-02 알타나 파마 아게 8-트리알킬실록시-2-메틸-9-페닐-7-옥소-7,8,9,10-테트라히드로이미다조[1,2-ｈ][1,7]나프티리딘
EP1599175A2 (en) * 2003-02-17 2005-11-30 ALTANA Pharma AG Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
PL1784404T3 (pl) 2004-09-03 2012-04-30 Yuhan Corp Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania
EP1784403B1 (en) 2004-09-03 2013-07-17 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
US8148529B2 (en) 2004-09-03 2012-04-03 Yuhan Corporation Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
WO2011004882A1 (ja) * 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
KR101699145B1 (ko) * 2012-06-15 2017-02-03 (주)바이오팜솔루션즈 페닐알킬설파메이트 화합물 및 이를 포함하는 근육 이완제 조성물
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3855692D1 (de) 1987-07-16 1997-01-16 Byk Gulden Lomberg Chem Fab Imidazo[1,2-a]pyridine
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
AU702166B2 (en) * 1994-07-28 1999-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridines
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
CU23088A3 (es) * 1997-03-24 2005-10-19 Altana Pharma Ag Compuestos de tetra-hidropiridina.
CZ292335B6 (cs) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethery, jejich použití a farmaceutický prostředek

Also Published As

Publication number Publication date
ES2191464T3 (es) 2003-09-01
HK1038360A1 (en) 2002-03-15
NO20011243D0 (no) 2001-03-12
ID28896A (id) 2001-07-12
AU763463B2 (en) 2003-07-24
PL193616B1 (pl) 2007-02-28
US6436953B1 (en) 2002-08-20
IL142063A (en) 2007-10-31
US7105676B2 (en) 2006-09-12
HRP20010224A2 (en) 2002-04-30
TR200100805T2 (tr) 2001-08-21
CZ292335B6 (cs) 2003-09-17
NO317304B1 (no) 2004-10-04
CN1319101A (zh) 2001-10-24
HK1038360B (en) 2003-05-16
AU6192099A (en) 2000-04-10
WO2000017200A1 (en) 2000-03-30
HUP0102990A3 (en) 2002-09-30
US6696460B2 (en) 2004-02-24
NZ510610A (en) 2003-07-25
EP1115725A1 (en) 2001-07-18
KR20010075223A (ko) 2001-08-09
ATE231862T1 (de) 2003-02-15
SK285165B6 (sk) 2006-07-07
JP2002526499A (ja) 2002-08-20
BR9914044A (pt) 2001-12-04
EA200100315A1 (ru) 2001-10-22
CN1560055A (zh) 2005-01-05
SK3992001A3 (en) 2001-12-03
DK1115725T3 (da) 2003-06-23
EE200100172A (et) 2002-06-17
EE04677B1 (et) 2006-08-15
PL346617A1 (en) 2002-02-25
US7393860B1 (en) 2008-07-01
CN100506821C (zh) 2009-07-01
HUP0102990A2 (hu) 2002-01-28
US20040162310A1 (en) 2004-08-19
CA2344251A1 (en) 2000-03-30
RS50145B (sr) 2009-03-25
BG65195B1 (bg) 2007-06-29
PT1115725E (pt) 2003-06-30
JP4145492B2 (ja) 2008-09-03
US20020169320A1 (en) 2002-11-14
CZ20011082A3 (cs) 2001-09-12
IL142063A0 (en) 2002-03-10
CN1155598C (zh) 2004-06-30
BG105270A (en) 2001-11-30
EA005377B1 (ru) 2005-02-24
NO20011243L (no) 2001-03-12
EP1115725B1 (en) 2003-01-29
SI1115725T1 (en) 2003-06-30
DE69905178D1 (de) 2003-03-06
KR100668400B1 (ko) 2007-01-17
DE69905178T2 (de) 2003-07-17
YU21401A (sh) 2004-03-12

Similar Documents

Publication Publication Date Title
GEP20032926B (en) Tetrahydropyridoethers
AU7031500A (en) Therapeutic quinazoline compounds
WO2003005971A3 (en) Tetracycline compounds having target therapeutic activities
NZ501069A (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
DK1137762T3 (da) Behandling af Pompes sygdom
SG140456A1 (en) Prevention and treatment of amyloidogenic disease
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
HUP0500041A3 (en) Oligonicleotide having 2'-o-(2-methoxyl)ethyl modifications and therapy using thereof
PT998287E (pt) Utilizacao de levobupivacaina
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
AU6254499A (en) Targeted therapy to a biomedical device
GB9907571D0 (en) Compounds
EP0744176A3 (en) Methods for inhibiting bone loss
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
AU6309999A (en) Therapeutic ankle orthosis
WO2001076590A3 (en) Treatment for benign positional vertigo using antiepileptics
AU9337598A (en) Magnetically therapeutic treatment device
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
HUP9904029A3 (en) Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis
AU1405001A (en) Treatment of diseases
AU1399100A (en) Therapeutic treatment with immunogenic drugs
AU1819799A (en) Externally worn medical device
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
GEU2000588Y (en) Medicinal Means Deprivazini
EP0895783A3 (de) Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin